Report

Global Vascular Boot Market Size Study, by Product Type, by Indication, by Distribution Channel and Regional Forecasts 2022-2032

  • Publish Date: Sep,2024
  • Report ID: 03-02-1943
  • Page : 200
  • Report Type : PDF (Email)
Global Vascular Boot Market is valued at approximately USD 1.13 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 3.26 % over the forecast period 2024-2032. Vascular boots are specialized medical devices designed to enhance blood circulation in the lower extremities, particularly for patients suffering from conditions such as peripheral artery disease (PAD) or chronic venous insufficiency. These boots utilize technologies such as intermittent pneumatic compression (IPC) to stimulate blood flow, reduce swelling, and prevent complications such as ulcers. By improving circulation, vascular boots aid in wound healing, alleviate pain, and minimize the risk of blood clots, thereby enhancing overall leg health and mobility.

The demand for vascular boots is driven by advances in healthcare technology and increased research and development activities are significantly boosting market growth. Additionally, rising healthcare spending and expenditures, coupled with a growing prevalence of diabetes and pressure-related injuries globally, are further propelling market expansion. Government initiatives aimed at addressing vascular disorders and the increased availability of point-of-care medical devices also contribute to the market's positive outlook. However, cost of advanced vascular boots is going to impede the overall demand for the market during the forecast period 2024-2032.

The key regions considered for the market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America is expected to dominate the vascular boots market throughout the forecast period. This dominance can be attributed to extensive R&D activities and significant healthcare spending in the region. Moreover, heightened awareness regarding various vascular conditions and injuries is anticipated to fuel market growth in North America. Furthermore, the market in Asia Pacific is anticipated to develop at the fastest rate over the forecast period 2024-2032.

Major market players included in this report are:
Medtronic
Becton
Boston Scientific Corporation
Biosensors International Group
Abbott
iVascular
Cardinal Health
Dickinson and Company
B. Braun Melsungen
Terumo Corporation
BIOTRONIK SE & Co. KG
Koninklijke Philips N.V.
Teleflex Incorporated
Cook Medical
AngioDynamics
The detailed segments and sub-segment of the market are explained below:
By Product Type:
Angioplasty Balloons
Angioplasty Stents
Catheters
EVAR Stent Grafts
Other Devices
Guidewires
Vascular Closure Devices
Introducer Sheaths
Balloon Inflation Devices
By Indication:
Heels
Ulcers
Limb
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region:
North America:
U.S.
Canada
Europe:
UK
Germany
France
Spain
Italy
ROE
Asia Pacific:
China
India
Japan
Australia
South Korea
RoAPAC
Latin America:
Brazil
Mexico
RoLA
Middle East & Africa:
Saudi Arabia
South Africa
RoMEA
Years considered for the study are as follows:
Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market